Genetic Association of Olanzapine Treatment Response in Han Chinese Schizophrenia Patients

Volume: 10
Published: Mar 4, 2019
Abstract
Olanzapine, a second-generation antipsychotic medication, plays a critical role in current treatment of schizophrenia (SCZ). It has been observed that the olanzapine responses in schizophrenia treatment are different across individuals. However, prediction of this individual-specific olanzapine response requires in-depth knowledge of biomarkers of drug response. Here, we performed an integrative investigation on 238 Han Chinese SCZ patients to...
Paper Details
Title
Genetic Association of Olanzapine Treatment Response in Han Chinese Schizophrenia Patients
Published Date
Mar 4, 2019
Volume
10
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.